Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction
Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.
OpenFDA device adverse-event casebook.
FDA MAUDE casebook
openFDA event book Filler MID-BOOK · MAUDE
#186 of 1000 · 13,040 reports · 2003–2026
- BOOK 13,040 reports
- RANK #186 of 1000
- DEATH 45 death-typed
- INJ 12,845 injury-typed
- MALF 90 malfunction
- SPAN 2003–2026
- PEAK 2013: 3,497
- PHOTO Pulse-Generator
Nearest event-volume peer: Pulse-Generator, Pacemaker, External (26 report gap)
Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction sits #186 of 1000 among tracked device types with 13,040 MAUDE reports spanning 2003–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →
Injury-coded reports run above the device-type norm
Filler carries 98.5% INJURY-coded reports, 68.2pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.
- DEATH 0.3% corpus 1.5% · below corpus mean (-1.2 pp)
- INJ 98.5% corpus 30.3% · above corpus mean (+68.2 pp)
- MALF 0.7% corpus 64.8% · below corpus mean (-64.1 pp)
Lead product-problem code Adverse Event Without Identified Device or Use Problem is 85% of coded problems · Lead manufacturer MEDTRONIC SOFAMOR DANEK USA, INC accounts for 87% of manufacturer-tagged reports · Top event location I is 50% of location-tagged rows .
Filler in the event-volume neighbourhood
FDA MAUDE report totals among this device type and nearest nationwide peers
- Bone Cement
Bone Cement
13,130 reports
- Filler (this)
Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction
13,040 reports
- Pulse-Generat…
Pulse-Generator, Pacemaker, External
13,014 reports
- Clamp
Clamp, Vascular
12,982 reports
- Electrode
Electrode, Ph, Stomach
12,853 reports
- Shoulder Pros…
Shoulder Prosthesis, Reverse Configuration
12,771 reports
What this shows Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction carries 13,040 MAUDE reports, ranked #186 of 1000.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Top Product Problems
Yearly Trend
Reports rose to 52 in 2025, up from an average of 25 in the two years before - a recent-year increase, not a lifetime pattern.
Related Entities for Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction
Top Manufacturers
Event Locations
Compare MEDTRONIC SOFAMOR DANEK USA, INC vs MEDTRONIC SOFAMOR DANEK USA, INC. →
Nationwide devices with a comparable volume-and-death footprint
Two openFDA-derived peer sets for Filler: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.
Similar report volume
Nearest other device types by FDA MAUDE report count (13,040 here).
Similar death-typed counts
Nearest other device types by death-typed report count (45 here), distinct from the volume row.
Read our methodology - how this data is sourced, computed, and verified.
Disclaimer: MAUDE figures for Filler are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.
Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Filler; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.